Option chain shows key data for CervoMed's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for CervoMed.

CervoMed (NASDAQ:CRVO) Stock, Option Chain

CervoMed

CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

GE Vernova Benefits from Gas Demand

News

Initiation

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

CADL

CMPX

CNCK

CRVO

This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

workday shutter2

Downgrades

QGEN

SUPN

TCMD

TECH

WDAY

This Workday Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Netapp,Sign,,Logo,On,Headquarters,Building,Facade,Of,Software,Company

Upgrades

GKOS

NTAP

This NetApp Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday

CervoMed Inc

Press Releases

CervoMed to Participate in Upcoming Investor Conferences

CervoMed Awarded the Prix Galien USA 2024 Prize for Best Startup

Earnings

CervoMed Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

Management

CervoMed Announces Key Senior Leadership Appointments

Health Care

CervoMed Announces Orphan Drug Designation Granted to Neflamapimod by U.S. Food and Drug Administration for the Treatment of Frontotemporal Dementia

Clinical Trial Results Show Positive Signs For Potential New Dementia Treatment

CervoMed Announces Topline Data from RewinD-LB Phase 2b Clinical Trial in Patients with Dementia with Lewy Bodies

CervoMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

General

CervoMed to Present at the 8th International Lewy Body Dementia Conference

CervoMed Provides Update on Neflamapimod DLB Program as Part of Presentation at the 8th International Lewy Body Dementia Conference

ABVC BioPharma

Akari Therapeutics Plc - American Depositary Shares

Akari Therapeutics

BioAtla

Bolt Biotherapeutics, Inc. - Common Stock

Bolt Biotherapeutics

Carisma Therapeutics, Inc. - Common Stock

CARISMA Therapeutics

Cardio Diagnostics Holdings Inc. - Common stock

Cardio Diagnostics Hldgs

Calidi Biotherapeutics, Inc. Common Stock

Calidi Biotherapeutics

GlycoMimetics

HCW Biologics

HOOKIPA Pharma

IN8bio

Kairos Pharma

Longeveron

Leap Therapeutics

Lisata Therapeutics

MEI Pharma

Marker Therapeutics

NKGen Biotech

Nanoviricides

NextCure

SAB Biotherapeutics

Spruce Biosciences

Synlogic

TC BioPharm (Holdings) plc - American Depositary Shares

TC BioPharm (Holdings)

Tenax Therapeutics

D. Boral Capital

Canaccord Genuity

Roth MKM

Morgan Stanley

Brookline Capital

Screenshot 2024-11-26 at 7.00.24 PM

Biotech

Interview

Comments

CervoMed

CervoMed (CRVO) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga